Analysis of FAERS data from 2003 to 2024 showed significant associations between diabetic retinopathy and semaglutide (PRR, 19.43), dulaglutide (PRR, 9.01), and liraglutide (PRR, 4.4) [95]
Effects of GLP-1 agonists on proportion of weight loss in obesity with or without diabetes: Systematic review and meta-analysis
For more details, review the Quartz Medicare Advantage Part D Drug Transition Policy or contact your Quartz Champion
What the research keeps pointing to is meals built on three things working together: protein, soluble fiber, and healthy fats
527 Conclusions and perspective Primarily recognized for their role in diabetes mellitus treatment, GLP-1RAs have demonstrated significant benefits in cardiovascular health, skeletal muscle-related diseases, obesity management, and neurodegenerative conditions, among others
Evidence suggests that the autonomic nervous system (ANS) is affected by dementia